| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-09 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |